{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:16Z","timestamp":1787678416013,"version":"build-2784847793"},"reference-count":20,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["public health action"],"accepted":{"date-parts":[[2026,5,4]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Non-coding RNAs (ncRNAs) have been shown to play essential roles in various human diseases, including pulmonary tuberculosis (TB). This study aims to investigate differentially expressed ncRNAs, explore their potential biological functions, and determine whether they can serve as biomarkers and therapeutic targets in TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Whole-transcriptome RNA sequencing was performed on blood samples from TB patients and healthy controls (n = 3 per group). Differentially expressed mRNAs, long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs) were identified, followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. A competing endogenous RNA (ceRNA) network was constructed, and hub genes were identified via protein\u2013protein interaction network analysis using Cytoscape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 507 differentially expressed mRNAs, 107 differentially expressed lncRNAs, 253 differentially expressed circRNAs, and 38 differentially expressed miRNAs were identified. Functional enrichment revealed involvement in pathways related to cellular processes, mTOR signalling, and endocytosis. A circRNA\u2013miRNA\u2013mRNA ceRNA network was constructed, and hub mRNAs including RACK1, EIF3G, and RPS15 were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>It is suggested that differentially expressed ncRNAs may play a role in the pathogenesis of TB. The circRNA (hsa_circ_0003340) and the hub mRNA (RACK1) are potential candidates for further exploration as biomarkers for TB infection. Moreover, the ceRNA network constructed in this study may provide new insights into the regulatory mechanisms of TB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5588\/pha.26.0020","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:25:08Z","timestamp":1787675108000},"page":"281-287","source":"Crossref","is-referenced-by-count":0,"title":["Whole-transcriptome sequencing analysis to identify key non-coding RNAs in the pathogenesis of pulmonary tuberculosis"],"prefix":"10.5588","volume":"16","author":[{"given":"M.-B.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.-Q.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3554","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"issue":"1","key":"2026082509245398000_16.3.281.1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13567-025-01670-1","article-title":"Immunopathogenesis of tuberculosis: cellular mechanisms and immune modulation","volume":"57","author":"Agull\u00f3-Ros","year":"2025","journal-title":"Vet Res"},{"key":"2026082509245398000_16.3.281.2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25122"},{"key":"2026082509245398000_16.3.281.3","doi-asserted-by":"publisher","DOI":"10.1038\/S41579-025-01201-X"},{"key":"2026082509245398000_16.3.281.4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-3-031-96883-9_11","article-title":"Future Research Directions on Mycobacterium tuberculosis Proteins","volume":"1484","author":"Farnia","year":"2026","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"2026082509245398000_16.3.281.5","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/pharmaceutics17111459","article-title":"Advanced nanosystems and emerging therapies: innovations in tuberculosis treatment and drug resistance","volume":"17","author":"Sharma","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026082509245398000_16.3.281.6","doi-asserted-by":"crossref","first-page":"101574","DOI":"10.1016\/j.cimid.2020.101574","article-title":"Drug resistant tuberculosis: a review","volume":"74","author":"Khawbung","year":"2021","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2026082509245398000_16.3.281.7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00141-20"},{"key":"2026082509245398000_16.3.281.8","doi-asserted-by":"crossref","first-page":"105060","DOI":"10.1016\/j.critrevonc.2025.105060","article-title":"Adaptive drug resistance mechanisms driven by non-coding RNA-protein interaction networks in hepatocellular carcinoma","volume":"218","author":"Tian","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026082509245398000_16.3.281.9","doi-asserted-by":"crossref","first-page":"1542686","DOI":"10.3389\/fimmu.2025.1542686","article-title":"The role of circular RNA in immune response to tuberculosis and its potential as a biomarker and therapeutic target","volume":"16","author":"Hong","year":"2025","journal-title":"Front Immunol"},{"issue":"12","key":"2026082509245398000_16.3.281.10","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1007\/s11033-022-07819-x","article-title":"LncRNAs in neuropsychiatric disorders and computational insights for their prediction","volume":"49","author":"Baruah","year":"2022","journal-title":"Mol Biol Rep"},{"issue":"7","key":"2026082509245398000_16.3.281.11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/genes14071375","article-title":"miRNAs: potential as biomarkers and therapeutic targets for cancer","volume":"14","author":"Chakrabortty","year":"2023","journal-title":"Genes (Basel)"},{"issue":"11","key":"2026082509245398000_16.3.281.12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/CM9.0000000000002595","article-title":"Emerging role of miRNAs, lncRNAs, and circRNAs in pregnancy-associated diseases","volume":"136","author":"Fu","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"2026082509245398000_16.3.281.13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073630"},{"key":"2026082509245398000_16.3.281.14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00050"},{"issue":"23","key":"2026082509245398000_16.3.281.15","doi-asserted-by":"crossref","first-page":"13056","DOI":"10.3390\/ijms252313056","article-title":"CircRNAs and miRNAs: key player duo in breast cancer dynamics and biomarkers for breast cancer early detection and prevention","volume":"25","author":"Maatouk","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2026082509245398000_16.3.281.16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/biom12091235","article-title":"Promising roles of circular RNAs as biomarkers and targets for potential diagnosis and therapy of tuberculosis","volume":"12","author":"Huang","year":"2022","journal-title":"Biomolecules"},{"key":"2026082509245398000_16.3.281.17","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2147\/CMAR.S290088","article-title":"CircRNA circ-OGDH (hsa_circ_0003340) acts as a ceRNA to regulate glutamine metabolism and esophageal squamous cell carcinoma progression by the miR-615-5p\/PDX1 axis","volume":"13","author":"Liang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2026082509245398000_16.3.281.18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41392-022-00945-9","article-title":"MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K\/Akt signaling","volume":"7","author":"Shen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026082509245398000_16.3.281.19","doi-asserted-by":"crossref","first-page":"901228","DOI":"10.3389\/fgene.2022.901228","article-title":"KMT5B is required for early motor development","volume":"13","author":"Hulen","year":"2022","journal-title":"Front Genet"},{"key":"2026082509245398000_16.3.281.20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba4733"}],"container-title":["Public Health Action"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.5588\/pha.26.0020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:25:10Z","timestamp":1787675110000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.theunion.org\/lookup\/doi\/10.5588\/pha.26.0020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,1]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.5588\/pha.26.0020"],"URL":"https:\/\/doi.org\/10.5588\/pha.26.0020","relation":{},"ISSN":["2220-8372"],"issn-type":[{"value":"2220-8372","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}